01228.HK
CANbridge Pharmaceuticals Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 2.01
+4.97%Leverage
- Debt / equity
- -0.15x
- Net debt / equity
- 0.30x
- Debt / assets
- 0.15x
- Debt / EBITDA
- -0.33x
- Net debt / EBITDA
- 0.68x
Liquidity & coverage
- Current ratio
- 0.43x
- Quick ratio
- 0.36x
- Cash ratio
- 0.26x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -HKD 226.0M
Cash & dividend
- FCF / debt
- -1.02x
- Cash flow / debt
- -1.02x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026